Progyny Inc
NASDAQ:PGNY

Watchlist Manager
Progyny Inc Logo
Progyny Inc
NASDAQ:PGNY
Watchlist
Price: 15.27 USD -3.05% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
Progyny Inc?
Write Note

Progyny Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Progyny Inc
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Progyny Inc
NASDAQ:PGNY
Gross Profit
$246.8m
CAGR 3-Years
32%
CAGR 5-Years
44%
CAGR 10-Years
N/A
UnitedHealth Group Inc
NYSE:UNH
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centene Corp
NYSE:CNC
Gross Profit
$16.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Molina Healthcare Inc
NYSE:MOH
Gross Profit
$6.3B
CAGR 3-Years
18%
CAGR 5-Years
16%
CAGR 10-Years
18%
Humana Inc
NYSE:HUM
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Elevance Health Inc
NYSE:ELV
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Progyny Inc
Glance View

Market Cap
1.3B USD
Industry
Health Care

Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 311 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The firm provides its benefit through its Smart Cycle approach. The Smart Cycle includes medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition, to its fertility benefits solution, it offers an integrated pharmacy benefits solution, Progyny Rx, which is added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. As part of this solution, the Company provide care management services, which include its formulary plan design, simplified authorization, assistance with prescription fulfillment and timely delivery of the medications by its network of specialty pharmacies, as well as medication administration training, pharmacy support services and patient care advocates.

PGNY Intrinsic Value
38.58 USD
Undervaluation 60%
Intrinsic Value
Price

See Also

What is Progyny Inc's Gross Profit?
Gross Profit
246.8m USD

Based on the financial report for Sep 30, 2024, Progyny Inc's Gross Profit amounts to 246.8m USD.

What is Progyny Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
44%

Over the last year, the Gross Profit growth was 9%. The average annual Gross Profit growth rates for Progyny Inc have been 32% over the past three years , 44% over the past five years .

Back to Top